Table 2 Patients complications up to 30 days after surgery
From: Postoperative outcomes in surgical COVID-19 patients: a multicenter cohort study
Variables | COVID-19 patients (n = 44) | Symptomatic (n = 26) | Asymptomatic (n = 18) |
|---|---|---|---|
Complications | |||
Pulmonary complications | 11 (25%) | 9 (35%) | 2 (11%) |
Infectious complications (non-pulmonary) | 4 (9%) | 1 (4%) | 3 (17%) |
Acute kidney injurya | 8 (18%) | 4 (15%) | 4 (22%) |
Thromboembolic complications | 2 (5%) | 2 (8%) | 0 (0%) |
Resource utilization | |||
New ICU admissions | 12 (27%) | 10 (39%) | 2 (11%) |
Hospital length of stay | 17 [4, 36] | 22 [6, 40] | 7 [3, 22] |
Mechanical ventilation free days (at 30 days) | 27.0 (7.4) | 25.0 (9.1) | 29.9 (0.3) |
Organ dysfunction-free days (at 30 days) | 25.2 (9.3) | 22.2 (11.1) | 29.6 (1.4) |
Mortality | |||
30-day mortality | 7 (15.9%) | 6 (23.1%) | 1 (5.6%) |
Kaplan-Meir survival probabilityb | 0.84 [0.74, 0.96] | 0.77 [0.62, 0.95] | 0.94 [0.84, 1.00] |